ADENTRA (ADEN) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
16 Mar, 2026Executive summary
Achieved Q3 sales of $592.1 million, up 4.1% year-over-year, with Adjusted EBITDA of $49.9 million and gross margin at 21.4%, reflecting both acquisition and organic growth despite a soft residential construction market and macro uncertainty.
Woolf Distributing acquisition contributed 2.4% to sales growth and broadened Midwest presence, with integration smooth and accretive.
Organic sales grew 1.7% as product prices firmed.
Maintained robust cash generation, with $60.6 million in operating cash flow supporting debt reduction and $7.4 million returned to shareholders via dividends and buybacks.
Financial highlights
Q3 sales increased by $23.3 million to $592.1 million; US sales up 4.4% to $548.1 million, Canada sales up 1.2% to C$60.6 million.
Gross margin rose to $126.4 million, with margin percentage at 21.4%.
Adjusted EBITDA was $49.9 million (up 3.9%), with margin at 8.4%.
Net income was $10.1 million ($0.42 per share); Adjusted EPS was $0.70.
Operating expenses rose 5% due to inflation and LTIP adjustments.
Outlook and guidance
Q4 expected to be seasonally slower, with Adjusted EBITDA projected to be similar to Q1 (~$40 million).
Gross margin percentage expected to remain consistent with Q3 and prior quarters.
Company remains cautious due to high US mortgage rates, limited housing inventory, and trade tensions, but is optimistic about long-term sector growth.
Continued focus on operating efficiency, organic growth, and disciplined M&A.
Capital allocation will focus on reducing leverage and preparing for strategic acquisitions in 2026.
Latest events from ADENTRA
- Sustained growth, strategic acquisitions, and operational excellence drive long-term value creation.ADEN
Investor presentation16 Mar 2026 - Strong growth, disciplined M&A, and operational excellence drive double-digit returns.ADEN
Investor presentation16 Mar 2026 - 2025 sales and net income grew, with robust cash flow, higher margins, and increased dividends.ADEN
Q4 202512 Mar 2026 - Net income and margins surged in Q2 2024 despite lower sales, driven by cost discipline and M&A.ADEN
Q2 20241 Feb 2026 - Sales up 1.8% to $568.8M, net income up 28.7%, gross margin 21.3%, and dividend increased.ADEN
Q3 202414 Jan 2026 - 2024 sales fell 2.5% but net income rose 28.9% as margins and US reach improved.ADEN
Q4 202426 Dec 2025 - Sales up 1.4% on acquisition, but organic sales and profit fell amid macro headwinds.ADEN
Q1 202524 Nov 2025 - Q2 sales up 8.7% to $597.1M, with margin growth and strong cash flow despite trade risks.ADEN
Q2 202523 Nov 2025 - Sustained growth, strong M&A, and operational excellence drive double-digit shareholder returns.ADEN
Investor Presentation7 Aug 2025